ADP-Ribosylation: Metabolic Effects and Regulatory Functions 1994
DOI: 10.1007/978-1-4615-2614-8_22
|View full text |Cite
|
Sign up to set email alerts
|

ADP-ribosylation factors: a family of ~20-kDa guanine nucleotide-binding proteins that activate cholera toxin

Abstract: ADP-ribosylation factors (ARFs) comprise a family of ~20 kDa guanine nucleotide-binding proteins that were discovered as one of several cofactors required in cholera toxin-catalyzed ADP-ribosylation of G, the guanine nucleotide-binding protein responsible for stimulation of adenylyl cyclase, and was subsequently found to enhance all cholera toxin-catalyzed reactions and to directly interact with, and activate the toxin. ARF is dependent on GTP or its analogues for activity, binds GTP with high affinity in the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

1996
1996
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 81 publications
0
10
0
Order By: Relevance
“…Thus, point mutations in the Y149 residue were predicted to disrupt CTA1–ARF interactions without eliminating the basal enzymatic activity of the toxin. We chose this approach to study CTA1–ARF interactions because any ARF protein can activate CTA1 (Price et al ., ; Welsh et al ., ), and it is not practical to eliminate the in vivo expression or activity of all ARFs. The established role of ARF1 in CT trafficking to the ER (Morinaga et al ., ; Richards et al ., ) would further complicate studies of CTA1–ARF interactions in the cytosol, as the loss of ARF1 function would disrupt an event upstream of toxin activity in the cytosol.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Thus, point mutations in the Y149 residue were predicted to disrupt CTA1–ARF interactions without eliminating the basal enzymatic activity of the toxin. We chose this approach to study CTA1–ARF interactions because any ARF protein can activate CTA1 (Price et al ., ; Welsh et al ., ), and it is not practical to eliminate the in vivo expression or activity of all ARFs. The established role of ARF1 in CT trafficking to the ER (Morinaga et al ., ; Richards et al ., ) would further complicate studies of CTA1–ARF interactions in the cytosol, as the loss of ARF1 function would disrupt an event upstream of toxin activity in the cytosol.…”
Section: Resultsmentioning
confidence: 99%
“…Consistent with this model, we have reported that lipid rafts exhibit a chaperone‐like interaction with CTA1 which is required for optimal in vivo toxin activity (Ray et al ., ). Gsα is located in lipid rafts at the cytoplasmic face of the plasma membrane (Oh and Schnitzer, ; Allen et al ., ; Kamata et al ., ), and, in vivo , GTP‐bound ARF proteins associate with membranes by virtue of their N‐terminal lipid modifications (Welsh et al ., ; Moss and Vaughan, ). Thus, the host factors required for optimal CTA1 activity are in proximity to the Gsα target.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In metazoans, three distinct classes of Arf proteins can be discriminated through phylogenetic analysis of peptide sequence and gene structure (Welsh et al 1994). However, this division is still obscure for plants, fungi and protists.…”
Section: Discussionmentioning
confidence: 99%